|
1
|
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.
|
Am J Hum Genet
|
2007
|
4.52
|
|
2
|
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
|
Nature
|
2009
|
3.80
|
|
3
|
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
|
Nat Genet
|
2010
|
2.47
|
|
4
|
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells.
|
Int J Cancer
|
2007
|
1.72
|
|
5
|
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.
|
Blood
|
2010
|
1.70
|
|
6
|
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
|
Mol Cancer Res
|
2009
|
1.53
|
|
7
|
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
|
Clin Cancer Res
|
2007
|
1.53
|
|
8
|
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.
|
Exp Hematol
|
2005
|
1.45
|
|
9
|
Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.
|
Blood
|
2008
|
1.30
|
|
10
|
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer.
|
Clin Cancer Res
|
2007
|
1.26
|
|
11
|
Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
|
Cancer
|
2004
|
1.25
|
|
12
|
SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.
|
Oncol Rep
|
2006
|
1.20
|
|
13
|
Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.
|
Haematologica
|
2009
|
1.17
|
|
14
|
Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
|
Cancer
|
2008
|
1.16
|
|
15
|
ERCC5 is a novel biomarker of ovarian cancer prognosis.
|
J Clin Oncol
|
2008
|
1.15
|
|
16
|
2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
|
Cancer
|
2005
|
1.12
|
|
17
|
Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
|
Mol Cancer Res
|
2005
|
1.12
|
|
18
|
Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.
|
Int J Cancer
|
2009
|
1.12
|
|
19
|
Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.
|
Blood
|
2007
|
1.10
|
|
20
|
SOX7 is down-regulated in lung cancer.
|
J Exp Clin Cancer Res
|
2013
|
1.08
|
|
21
|
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.
|
Clin Cancer Res
|
2008
|
1.06
|
|
22
|
Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.
|
Leuk Res
|
2006
|
1.01
|
|
23
|
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.
|
Haematologica
|
2009
|
0.99
|
|
24
|
Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
|
Int J Cancer
|
2009
|
0.94
|
|
25
|
Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
|
Haematologica
|
2010
|
0.91
|
|
26
|
[Zygomycosis: two case reports and review of reported cases in the literature in Japan].
|
Nihon Ishinkin Gakkai Zasshi
|
2003
|
0.91
|
|
27
|
The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias.
|
Hum Mol Genet
|
2010
|
0.90
|
|
28
|
Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells.
|
Haematologica
|
2009
|
0.89
|
|
29
|
Ancient ubiquitous protein 1 binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin alpha subunits that plays a crucial role in the inside-out signaling of alpha IIbbeta 3.
|
J Biol Chem
|
2002
|
0.89
|
|
30
|
Chronic phase of ETV6-ABL1 positive CML responds to imatinib.
|
Genes Chromosomes Cancer
|
2008
|
0.89
|
|
31
|
Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.
|
Leuk Res
|
2008
|
0.85
|
|
32
|
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
|
Blood
|
2009
|
0.85
|
|
33
|
Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
|
Jpn J Cancer Res
|
2002
|
0.79
|
|
34
|
Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization.
|
Leuk Res
|
2008
|
0.79
|
|
35
|
Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
|
Int J Hematol
|
2003
|
0.77
|
|
36
|
Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.
|
Endocrine
|
2013
|
0.76
|
|
37
|
Epstein-Barr virus-associated T-cell acute lymphoblastic leukaemia.
|
Br J Haematol
|
2002
|
0.76
|